Molecular characterization of the HIV type 1 subtype C accessory genes vif, vpr, and vpu

被引:18
作者
Bell, Catherine M.
Connell, Bridgette J.
Capovilla, Alexio
Venter, Willem D. F.
Stevens, Wendy S.
Papathanasopoulos, Maria A. [1 ]
机构
[1] Univ Witwatersrand, Dept Mol Med & Haematol, HIV Pathogenesis Res Lab, Sch Med, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Med, Reprod Hlth & HIV Res Unit, ZA-2193 Johannesburg, South Africa
关键词
D O I
10.1089/aid.2006.0181
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 Vif, Vpr, and Vpu proteins have a profound effect on efficient viral replication and pathogenesis. This study describes the genotypic characterisation of vif, vpr and vpu from 20 South African HIV-1 subtype C primary isolates, and extensive analysis and comparison of known motifs. All HIV-1 subtype C Vif, Vpr and Vpu proteins revealed the presence of highly conserved structural and functional motifs similar to other subtypes, for example, the Vif-APOBEC3G interaction domains. However, several differences were noted when these sequences were compared to subtype B, such as the presence of the LRLL motif which has been implicated in targeting subtype C Vpu predominantly to the cell surface, instead of the Golgi apparatus. A better understanding of the structure/function relationship of these proteins may lead to the development of new classes of antiviral drugs. These results indicate that antiviral drugs that target the conserved functional domains within Vif, Vpr or Vpu could be active against all circulating subtypes, including HIV-1 subtype C.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
[1]   HIV-1 Vpu sequesters β-transducin repeat-containing protein (βTrCP) in the cytoplasm and provokes the accumulation of β-catenin and other SCFβTrCP substrates [J].
Besnard-Guerin, C ;
Belaïdouni, N ;
Lassot, I ;
Segeral, E ;
Jobart, A ;
Marchal, C ;
Benarous, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) :788-795
[2]   The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release [J].
Bour, S ;
Strebel, K .
MICROBES AND INFECTION, 2003, 5 (11) :1029-1039
[3]   Computational analysis of mutations in the transmembrane region of Vpu from HIV-1 [J].
Candler, A ;
Featherstone, M ;
Ali, R ;
Maloney, L ;
Watts, A ;
Fischer, WB .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1716 (01) :1-10
[4]   The structure of the HIV-1 Vpu ion channel: modelling and simulation studies [J].
Cordes, FS ;
Kukol, A ;
Forrest, LR ;
Arkin, IT ;
Sansom, MSP ;
Fischer, WB .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1512 (02) :291-298
[5]   Interactions of the C-terminus of viral protein R with nucleic acids are modulated by its N-terminus [J].
de Rocquigny, H ;
Caneparo, A ;
Delaunay, T ;
Bischerour, J ;
Mouscadet, JFO ;
Roques, BP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (12) :3654-3660
[6]   Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages [J].
Ewart, GD ;
Nasr, N ;
Naif, H ;
Cox, GB ;
Cunningham, AL ;
Gage, PW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2325-2330
[7]   Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation [J].
Farrow, MA ;
Somasundaran, M ;
Zhang, CS ;
Gabuzda, D ;
Sullivan, JL ;
Greenough, TC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (06) :565-574
[8]   Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation [J].
Fujita, M ;
Akari, H ;
Sakurai, A ;
Yoshida, A ;
Chiba, T ;
Tanaka, K ;
Strebel, K ;
Adachi, A .
MICROBES AND INFECTION, 2004, 6 (09) :791-798
[9]   Viroporins [J].
Gonzalez, ME ;
Carrasco, L .
FEBS LETTERS, 2003, 552 (01) :28-34
[10]   Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease [J].
Hutoran, M ;
Britan, E ;
Baraz, L ;
Blumenzweig, I ;
Steinitz, M ;
Kotler, M .
VIROLOGY, 2004, 330 (01) :261-270